Ht-Logo-gigapixel-icon
Search
Close this search box.
Ht-Logo-gigapixel-icon
Search
Close this search box.
Saturday, November 2, 2024
Canada’s Politics and Government News Source Since 1989
Latest Paper
Saturday, November 2, 2024 | Latest Paper
Subscribe Now

TRENDING:

Rob Henderson

Rob Henderson, president and CEO of BioTalent Canada, is a seasoned executive with more than 25 years of private and public sector management experience. He’s a member of the National Stakeholders Advisory Panel for the Labour Market Information Council.

Developing Canada’s vaccine infrastructure for future pandemics will depend on addressing bio-economy labour shortages

  • After having to depend exclusively on international partners for COVID-19 vaccines, it’s encouraging to see Canada investing heavily in infrastructure projects to build our
Opinion | BY ROB HENDERSON | September 13, 2021
The challenges of developing made-in-Canada vaccines may sound daunting, but Canada has done it before. We have a strong track record of innovation and vaccine development, including helping bring the polio vaccine to the world in the 1950s, writes Rob Henderson. Image courtesy of Pixabay

Developing Canada’s vaccine infrastructure for future pandemics will depend on addressing bio-economy labour shortages

Opinion | BY ROB HENDERSON | September 13, 2021
  • After having to depend exclusively on international partners for COVID-19 vaccines, it’s encouraging to see Canada investing heavily in infrastructure projects to build our

Developing Canada’s vaccine infrastructure for future pandemics will depend on addressing bio-economy labour shortages

Opinion | BY ROB HENDERSON | September 13, 2021
  • After having to depend exclusively on international partners for COVID-19 vaccines, it’s encouraging to see Canada investing heavily in infrastructure projects to build our
The challenges of developing made-in-Canada vaccines may sound daunting, but Canada has done it before. We have a strong track record of innovation and vaccine development, including helping bring the polio vaccine to the world in the 1950s, writes Rob Henderson. Image courtesy of Pixabay

Developing Canada’s vaccine infrastructure for future pandemics will depend on addressing bio-economy labour shortages

  • After having to depend exclusively on international partners for COVID-19 vaccines, it’s encouraging to see Canada investing heavily in infrastructure projects to build our
Opinion | BY ROB HENDERSON | September 13, 2021
The challenges of developing made-in-Canada vaccines may sound daunting, but Canada has done it before. We have a strong track record of innovation and vaccine development, including helping bring the polio vaccine to the world in the 1950s, writes Rob Henderson. Image courtesy of Pixabay

Developing Canada’s vaccine infrastructure for future pandemics will depend on addressing bio-economy labour shortages

Opinion | BY ROB HENDERSON | September 13, 2021
  • After having to depend exclusively on international partners for COVID-19 vaccines, it’s encouraging to see Canada investing heavily in infrastructure projects to build our

Developing Canada’s vaccine infrastructure for future pandemics will depend on addressing bio-economy labour shortages

Opinion | BY ROB HENDERSON | September 13, 2021
  • After having to depend exclusively on international partners for COVID-19 vaccines, it’s encouraging to see Canada investing heavily in infrastructure projects to build our
The challenges of developing made-in-Canada vaccines may sound daunting, but Canada has done it before. We have a strong track record of innovation and vaccine development, including helping bring the polio vaccine to the world in the 1950s, writes Rob Henderson. Image courtesy of Pixabay
More Stories

News

Get free news updates

Opinion

Submit a guest opinion article

resources

Advertise

get help

Subscribe
CloseMenu